Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.

Best practice & research. Clinical endocrinology & metabolism - 1 Apr 2013

Karlas Thomas, Wiegand Johannes, Berg Thomas

Abstract excerpt

Obesity is a major risk factor for malign and non-malign diseases of the gastrointestinal tract. Non-alcoholic fatty liver disease (NAFLD) is an outstanding example for the complex pathophysiology of the metabolic system and represents both source and consequence of the metabolic syndrome. NAFLD has a growing prevalence and will become the leading cause of advanced liver disease and cirrhosis. Obesity has a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fatty Liver
Share to Gastrointestinal Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Incidence

Share to Metabolic Syndrome

Share to Non-alcoholic Fatty Liver Disease

Share to Obesity

Share to Prevalence

Source

Identifiers

PMID: 23731881
DOI: 10.1016/j.beem.2013.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.PMID 23731881Read ↗

Obesity and the liver: nonalcoholic fatty liver disease.Semantic proximity Read ↗

Non-alcoholic fatty liver disease: what the clinician needs to know.Semantic proximity Read ↗

Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.Semantic proximity Read ↗

Non-alcoholic fatty liver disease.Semantic proximity Read ↗

Advancements in Understanding and Treating NAFLD: A Comprehensive Review of Metabolic-Associated Fatty Liver Disease and Emerging TherapiesSemantic proximity Read ↗

Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk FactorsSemantic proximity Read ↗

Non-alcoholic fatty liver disease pathogenesis: the present and the future.Semantic proximity Read ↗

Nonalcoholic fatty liver disease.Semantic proximity Read ↗

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).Semantic proximity Read ↗

Recent advances in understanding and managing non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Metabolic drivers of non-alcoholic fatty liver disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.